Dr. Peter Kash
Co-founder and Vice Chairman of the Board of Directors of iOncologi, he leads an international effort that is transforming the treatment of glioblastoma and pediatric osteosarcoma, two of the most aggressive cancers in children. After more than a decade of research, iOncologi already has two platforms in human clinical trials and plans to expand its studies to Mexico and Argentina, in addition to its current collaborations in Florida (USA) and the Sheba Medical Center in Israel. Its model integrates next-generation immunotherapies, precision administration, and artificial intelligence, with the goal of overcoming historical barriers such as tumor heterogeneity and the blood-brain barrier, paving the way for universal and personalized therapies against incurable solid tumors. Beyond his scientific impact, Dr. Kash also stands out for his philanthropic commitment: his book “Take Two Tablets: Medicine From the Bible,” recently translated into Spanish as “La Medicina en la Biblia,” donates 100% of its royalties to the purchase of Sony PlayStations, which are donated to hospitals in South America, Mexico, and Spain to improve the quality of life for children with cancer. This project combines cutting-edge science with empathy and social responsibility, showing how innovation can transform both the health and hope of thousands of families.
BIOGRIP TECH
Wireless nerve-machine interface that connects Ecos robotic systems with the human body. With just a thought, the device learns to perform natural, simultaneous, and complex movements.
Griyum
They produce ingredients with maximum nutrients and minimal environmental impact using edible crickets farmed in rural communities. Easy to integrate into recipes and formulations for bakery products, cookies, tortillas, supplements, and meat analogs.
Dr. Vagón
The Health Train has 17 cars and an operating room, making it possible to provide laboratory and diagnostic studies, general and specialty medical consultations, and family planning; we have a clinic specialized in comprehensive health for women and diabetic patients. With this, it is possible to provide FREE high-quality medical services.
Eviter
Gresmex, a Mexican company with over 20 years of experience and an international presence, has developed a unique nano-bio molecule, patented in more than 100 countries, whose main benefits are: Acting directly on the DNA or RNA of viruses, bacteria, fungi, spores, and mycobacteria, so they cannot develop resistance. It is neither corrosive nor cytotoxic. It is 100% harmless and biodegradable. Its safety and efficacy have been proven by multiple laboratories in Mexico and around the world.
Liver Health
Campaign
Clara Lau, General Director of Biomédica de Referencia, President of COMED, the Mexican Council of Diagnostic Companies, an organization that brings together the largest and most prestigious laboratories and clinics in the country, who have collaboratively promoted the initiative for the definition and establishment of the biosafety protocols required to guarantee the correct collection and handling of biological samples, as well as the guidelines.
